Literature DB >> 23564757

Atypical Bickerstaff brainstem encephalitis: ataxic hypersomnolence without ophthalmoplegia.

Benjamin R Wakerley1, Derek Soon, Yee-Cheun Chan, Nobuhiro Yuki.   

Abstract

OBJECTIVE: Clinical and immunological evaluation of 'incomplete' Bickerstaff brainstem encephalitis (BBE).
METHODS: We studied two patients with postinfectious brainstem syndromes who presented at National University Hospital Singapore. Laboratory work-up included measurement of antiganglioside antibodies.
RESULTS: Both patients displayed hypersomnolence and cerebellar-like ataxia in the absence of external ophthalmoplegia and carried high serum titres of IgG anti-GQ1b antibodies, strongly indicative of BBE.
CONCLUSIONS: Ophthalmoplegia can be absent or incomplete in BBE, and the absence of this clinical feature should not exclude BBE from the clinicians' differential. Such cases of incomplete BBE could be defined as 'ataxic hypersomnolence without ophthalmoplegia'.

Entities:  

Keywords:  EYE MOVEMENTS; GUILLAIN-BARRE SYNDROME; IMMUNOLOGY; NEUROPATHY

Mesh:

Substances:

Year:  2013        PMID: 23564757     DOI: 10.1136/jnnp-2013-304993

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  5 in total

1.  Optic neuritis as a possible phenotype of anti-GQ1b/GT1a antibody syndrome.

Authors:  Damien Biotti; Sophie Boucher; Elodie Ong; Caroline Tilikete; Alain Vighetto
Journal:  J Neurol       Date:  2013-09-06       Impact factor: 4.849

2.  Bickerstaff's encephalitis.

Authors:  Emma Horton; Sanjay Krishnamoorthy; Lucy Reynolds
Journal:  BMJ Case Rep       Date:  2014-07-30

Review 3.  Prevalence, clinical characteristics and outcomes of Guillain-Barré syndrome spectrum associated with COVID-19: A systematic review and meta-analysis.

Authors:  Lina Palaiodimou; Maria-Ioanna Stefanou; Aristeidis H Katsanos; Paraskevi C Fragkou; Marianna Papadopoulou; Christos Moschovos; Ioannis Michopoulos; Panagiotis Kokotis; Christos Bakirtzis; Androniki Naska; Theodoros I Vassilakopoulos; Elisabeth Chroni; Sotirios Tsiodras; Georgios Tsivgoulis
Journal:  Eur J Neurol       Date:  2021-04-28       Impact factor: 6.288

4.  Bickerstaff encephalitis after COVID-19.

Authors:  Lucía Llorente Ayuso; Pedro Torres Rubio; Rafael Fernando Beijinho do Rosário; María Luisa Giganto Arroyo; Fernando Sierra-Hidalgo
Journal:  J Neurol       Date:  2020-09-03       Impact factor: 4.849

Review 5.  Guillain-Barré and Miller Fisher syndromes--new diagnostic classification.

Authors:  Benjamin R Wakerley; Antonino Uncini; Nobuhiro Yuki
Journal:  Nat Rev Neurol       Date:  2014-07-29       Impact factor: 42.937

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.